Abstract
This article explores the history of endocrine therapy for the treatment of breast cancer, the clinical evidence behind the current standards of care, and controversies that may change these standards in the future.
Original language | English |
---|---|
Pages (from-to) | 519-532 |
Number of pages | 14 |
Journal | Endocrinology and Metabolism Clinics of North America |
Volume | 40 |
Issue number | 3 |
DOIs | |
State | Published - Sep 2011 |
Keywords
- Antiestrogens
- Aromatase inhibitors
- Breast cancer
- GnRH agonist
- Hormonal modulation
- Ovarian suppression
- SERD
- SERM